Antibodies to infliximab (ATI) in serum are related to secondary lack of response (LOR) to infliximab (IFX) remedy in sufferers with inflammatory bowel illness (IBD).
![Immunology and Cancer Biology University of California](https://teitell-lab.com/hf/uploads/2021/04/teitell_lab_header.gif)
Immunology and Cancer Biology University of California
Apoptosis, flow, mitochrondria, FITC, cytoplasmic membrane, oncoprotein